AMPK isoform expression in the normal and failing hearts

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 1066-1073

  Kim, Maengjo ^a   Shen, Mei ^b   Ngoy, Soeun ^b   Karamanlidis, Georgios ^a   Liao, Ronglih ^b   Tian, Rong ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

AMPK; Heart failure; Human; Isoform expression; Mice

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA1 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE BETA1 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE BETA2 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA1 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA2 SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA2A SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE GAMMA2C SUBUNIT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ISOENZYME; ISOENZYME; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ADULT ANIMAL; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FETUS; GENE EXPRESSION; HEART DEVELOPMENT; HEART FAILURE; HEART HYPERTROPHY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; ISOENZYME ANALYSIS; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ADENYLATE KINASE; ADULT; AGED; ANIMALS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART FAILURE; HUMANS; ISOENZYMES; MALE; MICE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; YOUNG ADULT;

MUS; RODENTIA;

EID: 84862808312     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.016     Document Type: Article

References (28)

1. Zhang B.B., Zhou G., Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab May 2009, 9(5):407-416.
2. Hardie D.G. AMPK and Raptor: matching cell growth to energy supply. Mol Cell May 9 2008, 30(3):263-265.
3. Dasgupta B., Milbrandt J. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell Feb 2009, 16(2):256-270.
4. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci Jan 2004, 29(1):18-24.
5. Kemp B.E., Stapleton D., Campbell D.J., Chen Z.P., Murthy S., Walter M., et al. AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans Feb 2003, 31(Pt 1):162-168.
6. Hue L., Rider M.H. The AMP-activated protein kinase: more than an energy sensor. Essays Biochem 2007, 43:121-137.
7. Tian R., Musi N., D'Agostino J., Hirshman M.F., Goodyear L.J. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation Oct 2 2001, 104(14):1664-1669.
8. Russell R.R., Li J., Coven D.L., Pypaert M., Zechner C., Palmeri M., et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest Aug 2004, 114(4):495-503.
9. Gundewar S., Calvert J.W., Jha S., Toedt-Pingel I., Ji S.Y., Nunez D., et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ Res Feb 13 2009, 104(3):403-411.
10. Liao Y., Takashima S., Maeda N., Ouchi N., Komamura K., Shimomura I., et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc Res Sep 1 2005, 67(4):705-713.
11. Zhang P., Hu X., Xu X., Fassett J., Zhu G., Viollet B., et al. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension Nov 2008, 52(5):918-924.
12. Xing Y., Musi N., Fujii N., Zou L., Luptak I., Hirshman M.F., et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J Biol Chem Aug 1 2003, 278(31):28372-28377.
13. Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J., Teh T., et al. Mammalian AMP-activated protein kinase subfamily. J Biol Chem Jan 12 1996, 271(2):611-614.
14. Thornton C., Snowden M.A., Carling D. Identification of a novel AMP-activated protein kinase beta subunit isoform that is highly expressed in skeletal muscle. J Biol Chem May 15 1998, 273(20):12443-12450.
15. Cheung P.C., Salt I.P., Davies S.P., Hardie D.G., Carling D. Characterization of AMP-activated protein kinase gamma-subunit isoforms and their role in AMP binding. Biochem J Mar 15 2000, 346(Pt 3):659-669.
16. Liao R., Jain M., Cui L., D'Agostino J., Aiello F., Luptak I., et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation Oct 15 2002, 106(16):2125-2131.
17. Karamanlidis G., Nascimben L., Couper G.S., Shekar P.S., del Monte F., Tian R. Defective DNA replication impairs mitochondrial biogenesis in human failing hearts. Circ Res May 14 2010, 106(9):1541-1548.
18. Lang T., Yu L., Tu Q., Jiang J., Chen Z., Xin Y., et al. Molecular cloning, genomic organization, and mapping of PRKAG2, a heart abundant gamma2 subunit of 5'-AMP-activated protein kinase, to human chromosome 7q36. Genomics Dec 1 2000, 70(2):258-263.
19. Luo Z., Zang M., Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol Mar 2010, 6(3):457-470.
20. Jager S., Handschin C., St-Pierre J., Spiegelman B.M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc Natl Acad Sci USA Jul 17 2007, 104(29):12017-12022.
21. Makinde A.O., Gamble J., Lopaschuk G.D. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circ Res Apr 1997, 80(4):482-489.
22. Li J., Coven D.L., Miller E.J., Hu X., Young M.E., Carling D., et al. Activation of AMPK alpha- and gamma-isoform complexes in the intact ischemic rat heart. Am J Physiol Heart Circ Physiol Oct 2006, 291(4):H1927-H1934.
23. Salt I., Celler J.W., Hawley S.A., Prescott A., Woods A., Carling D., et al. AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the alpha2 isoform. Biochem J Aug 15 1998, 334(Pt 1):177-187. (Pt 1).
24. Hallows K.R., Kobinger G.P., Wilson J.M., Witters L.A., Foskett J.K. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells. Am J Physiol Cell Physiol May 2003, 284(5):C1297-C1308.
25. Evans A.M., Mustard K.J., Wyatt C.N., Peers C., Dipp M., Kumar P., et al. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells?. J Biol Chem Dec 16 2005, 280(50):41504-41511.
26. Suzuki A., Okamoto S., Lee S., Saito K., Shiuchi T., Minokoshi Y. Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol Jun 2007, 27(12):4317-4327.
27. Li H.L., Yin R., Chen D., Liu D., Wang D., Yang Q., et al. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy. J Cell Biochem Apr 1 2007, 100(5):1086-1099.
28. Dolinsky V.W., Chan A.Y., Robillard Frayne I., Light P.E., Des Rosiers C., Dyck J.R. Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1. Circulation Mar 31 2009, 119(12):1643-1652.